Cargando…
Evaluation of the Anticancer and Biological Activities of Istaroxime via Ex Vivo Analyses, Molecular Docking and Conceptual Density Functional Theory Computations
Cancer is a disease that occurs as a result of abnormal or uncontrolled growth of cells due to DNA damage, among many other causes. Certain cancer treatments aim to increase the excess of DNA breaks to such an extent that they cannot escape from the general mechanism of cell checkpoints, leading to...
Autores principales: | Gok, Ege, Unal, Naz, Gungor, Burcin, Karakus, Gulderen, Kaya, Savas, Canturk, Pakize, Katin, Konstantin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672917/ https://www.ncbi.nlm.nih.gov/pubmed/38005181 http://dx.doi.org/10.3390/molecules28227458 |
Ejemplares similares
-
Cellular Mechanisms Underlying the Low Cardiotoxicity of Istaroxime
por: Racioppi, María Florencia, et al.
Publicado: (2021) -
Istaroxime: A rising star in acute heart failure
por: Aditya, Suruchi, et al.
Publicado: (2012) -
Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure
por: Forzano, Imma, et al.
Publicado: (2022) -
Istaroxime, a potential anticancer drug in prostate cancer, exerts beneficial functional effects in healthy and diseased human myocardium
por: Wallner, Markus, et al.
Publicado: (2017) -
Istaroxime treatment ameliorates calcium dysregulation in a zebrafish model of phospholamban R14del cardiomyopathy
por: Kamel, S. M., et al.
Publicado: (2021)